Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-22

Clinical Trial Update: Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)

View source ↗

Summary

HYIMPACT is a prospective observational trial evaluating nebivolol (Nebilet) for blood pressure control in hypertensive patients and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebilet (nebivolol)

Snippet

Sponsor: A.Menarini Asia-Pacific Holdings Pte Ltd | Conditions: Hypertension | Status: RECRUITING